Schedule 13D ownership disclosure

VOR BIOPHARMA INC

Security class unavailable · CUSIP: 929033108

Event date: 2022-12-07

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
22,760,145
Percent of class
34.8000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-22-125891
Form type
SC 13D
Filer
RA CAPITAL MANAGEMENT, L.P.
CIK
CIK 1346824
Filed
Dec 09, 2022
Reporting period
Dec 07, 2022
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub